28.12.2013 Views

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Epidemiological, Virological Survey Following Oral Administration 141<br />

TABLE 2c. T MARKER AND INTRACEREBRAL NEUROVIRULENCE OF TYPE 3 STRAINS EXCRETED BY<br />

VACCINATED INDIVIDUALS<br />

MONKEY<br />

NEUROVIRULENCE<br />

VACCINEE<br />

NUMBER<br />

DAY AFTER<br />

VACCINE<br />

FEEDING<br />

TCDo0 LOG 10<br />

INOCULATED<br />

DIFFERENCE<br />

LOG TITER AT<br />

40 ° C. AND 37 0 C<br />

T MARKER<br />

6<br />

10<br />

14<br />

5<br />

14<br />

15<br />

+-<br />

8.0<br />

8.2<br />

7.9<br />

3.0<br />

0<br />

4.2<br />

I<br />

23<br />

26<br />

28<br />

29/1<br />

29/2<br />

114<br />

185/1<br />

8<br />

8<br />

29<br />

36<br />

44<br />

19<br />

9<br />

+<br />

7.6<br />

8.4<br />

8.0<br />

7.8<br />

7.2<br />

7.1<br />

6.3<br />

2.3<br />

4.8<br />

4.4<br />

1.0<br />

1.2<br />

5.5<br />

1.0<br />

T<br />

T<br />

T<br />

I<br />

185/2<br />

23<br />

+<br />

7.0<br />

3.5<br />

I<br />

188/1<br />

188/2<br />

191<br />

196/1<br />

196/2<br />

196/3<br />

9<br />

29<br />

13<br />

12<br />

21<br />

27<br />

+<br />

+<br />

+-<br />

+<br />

7.2<br />

6.2<br />

6.2<br />

6.3<br />

5.5<br />

6.0<br />

1.0<br />

1.5<br />

3.2<br />

1.0<br />

1.0<br />

1.0<br />

202/1<br />

12<br />

7.4<br />

3.0<br />

I<br />

202/2<br />

202/3<br />

19<br />

26<br />

+<br />

+-<br />

6.5<br />

6.7<br />

3.3<br />

0.2<br />

I1<br />

of one strain. Three strains excreted by vaccinee<br />

202 possessed the T character, which was correlated<br />

with absence of neurovirulence in those<br />

excreted on the 12th and 18th day, whereas that<br />

excreted on the 25th day exhibited intracerebral<br />

activity following inoculation of 106s8 TCD,,.<br />

Twelve of 16 Type 2 strains excreted by<br />

vaccinated individuals possessed the T character<br />

and four were intermediate, as recorded in Table<br />

2B. None of them showed evidence of neurovirulence<br />

following intracerebral inoculation of<br />

amounts of virus as high as 104.0 to 108.4 TCD 5 0 .<br />

A less regular pattern shows the Type 3<br />

strains (Table 2C). Ten of 20 strains excreted<br />

by vaccinated individuals possess the T+ character,<br />

and six of them exhibited intracerebral activity.<br />

Three of six intermediate strains showed<br />

evidence of increased neurovirulence. Moreover,<br />

one of four T strains produced paralysis after<br />

intracerebral inoculation of 107.9 TCD 50 .<br />

When summarizing these observations, regardless<br />

of the types, intracerebral activity has been<br />

shown in 2 of 33 (6 per cent) of the T strains,<br />

in 3 of 11 (27 per cent) of the intermediate<br />

strains and in 6 of 10 (60 per cent) of the T+<br />

strains excreted by vaccinated individuals.<br />

In conclusion, the genetic stability of the Type<br />

3 vaccine strain is less than that of Types 1 and<br />

2. Nevertheless, there has been no evidence of<br />

any harmful effect either to the vaccinated individuals<br />

or to the community in which all three

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!